Abstract
Introduction

Aim s and objectives
Since 1988, the popular media in Scotland has been reporting an apparent rise in the use of illicit drugs at dance events (ª Drugs Deals at thè acid ' Discoº , Scottish Daily Record, 13/11/88, ª ExposedÐ Disco Drugs Ring!º , Scottish Sunda y M ail,  08/03/92). Drug researchers have identi® ed this new pattern of drug use throughout the United Kingdom and beyond (Lyttle & Montague, 1992; M cD ermott, Matthews & Bennett, 1992) . Health educators in the 1990s have speci® cally referred to certain drugs as ª dance drugsº (Lifeline, 1992; Gilman, 1994) . To date much of the inform ation about drug use on the dance scene has been anecdotal or qualitative in nature. This paper aims to quantify drug use in the dance scene both at dance events and in other settings. It is intended to identify which drugs are used as dance drugs, and detail how these differ from other drugs used by the same population. It is important to quantify these patterns of drug use in the light of recent deaths at dance events. In attempting to explain these deaths, media speculation has tended to focus on the use of Ecstasy (M DM A) at ª ravesº (ª HUNT FOR KILLER ECST ASY: Deadly rave drug claims two more victimsº , Glasgow E vening Tim es, 02/05/94). This has led to the narrow equation that dance drugs equals M DM A; therefore any drug-related harm at dance events m ust be due to Ecstasy. Using data from 135 participants in the Glasgow dance scene it is intended to clarify which drugs are commonly used at dance events and which are not. The setting of drug use is identi® ed as being of particular signi® cance in this drug scene. The implications of this new pattern of drug use are also explored.
M ethod
Sam ple Data were collected from a sample of 135 respondents, who were interviewed between 1 December 1993 and 31 August 1994. The entry criterion for this sample was participation in the Glasgow dance drug scene (ª rave sceneº ). Respondents were recruited via purposive snowballing by using key contacts active in the Glasgow dance drug scene. These key contacts were people who ª workedº in the rave scene in the West End of Glasgow, such as DJs, electronic m usicians, youth workers, drug dealers or researchers. The term ª dance drug sceneº is used in this paper to cover all the dance/house/ garage/techno/rave/club scene that has evolved in Scotland since 1988. These respondents were recruited during a larger study funded by the Scottish Of® ce examining the socio-psychiatric effects of M DM A.
The sample had a mean age of 24 years (range 14± 44) and was 62% male. These demographics are similar to those of many other drug use studies carried out in Scotland during the last decade. For example, studies including Neville, McKellican & Foster (1988) , Hamm ersley et al. (1988) , Rahman, Ditton & Forsyth (1989) , Morrison & Plant (1990) , Lavelle et al. (1991 , 1993 and Rhodes et al. (1993) were all predominantly male and had a mean age between 24 and 26 years. However, in other ways the present sample differed dem ographically from ª traditionalº drug research samples. M ost of this group (80%) had been in further education, although 40% of the total were currently unemployed. Two-thirds (66% ) of these ª unemployedº did do irregular work, often in the dance drug scene itself. Only 10 individuals admitted to ever having injected drugs and only four had ever been imprisoned. Respondents in other Scottish drug studies have more typically been drug injectors with low levels of employment and extensive custodial histories. The dance drug group also had a different pattern of drug use from these other studies.
Instrum ent
The m ajority of the respondents (n 5 73) were interviewed in of® ces at the University of Glasgow. The remainder were interviewed in their homes, at a youth club or in rooms used by the local health trust. A structured instrument listing questions about a variety of differen t drugs was administered to each respondent. This asked questions about 16 speci® c categories of drugs and if any other drugs not listed had been taken. Data were recorded for up to three additional substances not listed. The 16 speci® c drug categories were alcohol, tobacco, cannabis, heroin, Buprenorphine, dihydrocodeine, Temazepam, Diazepam, solvents, cocaine, Amphetamines, LSD, Psilocybin, nitrites, Ketamine and Ecstasy.
Two sets of questions were asked about each drug category. First, the interviewer asked respondents whether they had ever used each of the drugs listed. If yes, the respondent was then asked how many days in the past week, month and year they had used it. They were then asked how much of the drug they used on the last occasion they had taken it and how old they were when they ® rst tried it. Finally, they were asked if they had ever injected each drug. These questions were designed to measure the level of involvement with each drug that the respondent had. That is, how m uch and how often dance drug users took each drug. This instrument design has been used elsewhere (Hammersley, Forsyth & Lavelle, 1990; Lavelle et al., 1991) , m aking these data directly comparable to data from other samples of drug users. In practice, this instrument was very ª user friendlyº with the dance scene group, as their drug use (excluding alcohol, tobacco and cannabis) was often related to speci® c dates, events, holidays or weekends. In other samples where this instrument has been used, respondents' recall was effected by the chaotic or habitual nature of their drug use, which often made periods of abstinence more m em orable than patterns of use.
Secondly, each respondent was asked a set of questions about the circumstances of last use of each drug. These were open-ended questions, the ® rst of which asked about the setting of last use. If this was at a dance event they were then asked for the name of that dance event. It should be noted that, in practice, the drug was often ingested shortly before entering the dance event, timing the onset of the effects with successful entry to the event. If last use was not at a dance event, they were asked to provide the name of the geographical area they were in at the time. Similarly, respondents were then asked where they obtained each drug (at which dance event or in which geographical area). This is an adaptation (to account for the advent of dance drug culture) of a method previously successfully em ployed elsewhere to measure levels of availability and dealing patterns for different drugs (Forsyth et al., 1992) . Respondents were also asked to say who they had obtained each drug from and how m uch (if anything) they had to pay for the amount of drugs they bought.
R esults
Overall pattern of drug use A total of 51 discrete drugs had been used by these respondents. The mean number of drugs used was 10.7 (maximum allowed 19), range 3± 18. Drugs used included all 16 categories speci® ed, plus a variety of others. These ® ndings are summarized in Table 1 . The others drugs not listed in the questionnaire were: Methadone (n 5 10), opium (11), Dipipanone (12), codeine (4), m orphine (5), pethidine (1), M eptazinol (1), Methaqualone (2), Triazolam (1), chlordiazepoxide (2), Lorazepam (1), Nitrazepam (2), anti-depressants (2), Prothiaden (2), GHB (1), barbiturates (4), ª zonksº (5), ª iceº (1), ª crackº (1), ether (1), chloroform (3), nitrous oxide (1), broom (1), ª magicº datura apples (1), beta blockers (1), nutmeg (3), m escaline (3), slimm ing pills (1), khat (1), ephedrine (1), Morning Glory seeds (1), synthetic ergot (1), Chlorprom azine (1), DOM (1) and C yclizine (1). This range of drugs includes stimulants, opiates, hallucinogens, depressants and anaesthetics. Such ® ndings may indicate a tendency to experiment with different substances. However, this group could not be described m erely as experimental drug users. In 15 of the 17 drug categories, at least half the respondents who had ever tried each drug had used it in the past year (the exceptions being solvents and Buprenorphine). In no sense could this dance drug group be classi® ed as users of a single substance, such as M DMA.
From Table 1 , it is clear that drugs with certain types of effects were more comm only used than those with other types. In terms of ever having been used, all hallucinogens and stimulants (cocaine, Am phetamine, Psilocybin, LSD and Ecstasy) had been taken by 70% or m ore of respondents. In contrast, all depressants (heroin, Buprenorphine, dihydrocodeine, Diazepam and solvents) had a life-time use by only 30% or less of this dance drug sample. The sole exception to this pattern was the benzodiazepine, Temazepam. This ® nding may con® rm the belief that Temazepam has intruded into the Scottish dance drug scene. This possibility has given rise to concerns that Tem azepam may act as an epidemiological bridge between ª problemº drug users and the dance scene (M cD erm ott & M cBride, 1993) . Although this sample is de® ned as an illegal dance drug using group, it is noteworthy that alcohol, tobacco and cannabis are by far the substances most frequently used.
Setting of drug use by da nce drug users
Different users m ay use different drugs in different locations. Korf, Blanken & Nabben (1991) identi® ed two types of Ecstasy (M DM A) user according to the setting of their drug use. These were de® ned as ª in-usersº and ª out-usersº . Inusers tended to take M DM A at home, out-users at a dance event. Korf stated that the in-users were not people who did not ª partyº , it was simply that this is not the setting in which they chose to use Ecstasy. In the present study, it is not so much the differences between drug users' choice of setting that is being compared (as they are by de® nition, out-users) but the differences between drugs, that is, between drugs which are used to ª partyº and drugs which are used elsewhere.
Among 135 dance drug users there was a clear distinction between drugs which were most often used at a dance event setting and those which were not. Table 2 shows the differen t settings in which drugs were used by respondents in this sample. Dance event settings (clubs, licensed raves or illegal parties) can be compared here with non-dance event settings (at home, another house, outside or in a pub). House parties (that is, in someone' s home) and other work/events, both of which may or may not involve dancing, tended to lie somewhere between these two extremes. It should be rem embered that`work' in this group often included working in the dance scene. Also, other events cited here included graduations, festivals, weddings, (conventional) discos, concerts, restaurants and onboard transport that was often travelling to or from a dance scene event.
From Table 2 , four drugs (Ecstasy, nitrites, Amphetamine and LSD) were more often last used in a dance setting than at any other. All pharm aceutical drugs (Buprenorphine, dihydrocodeine, Temazepam, Diazepam and Ketamine) were more likely to be used in the respondents' homes than anywhere else. This was also the case for the m ajority of tobacco and cannabis users. Heroin and cocaine were m ost comm only last used at another' s house. Solvents and Psilocybin were used outdoors more than in any other setting. Finally, alcohol was m ore often consumed in a pub than anywhere else.
Collapsing these subdivisions of setting into dance, non-dance and others, as described above, is even more revealing. A majority of users of alcohol, tobacco, cannabis, heroin, Buprenorphine, dihydrocodeine, Temazepam, Diazepam, solvents, cocaine, Psilocybin and Ketamine last did so in a non-dance setting. M ost users of Am phetamine, nitrites and Ecstasy last did so in a dance setting. LSD use was more evenly divided, the balance being held by other occasions. Although all drugs are represented in non-dance settings it is notable that some drugs, such as cannabis, dihydrocodeine, Diazepam and solvents, were almost totally absent from dance settings. Of those drugs which were last used by a majority of users in a non-dance setting, only alcohol and cocaine had 10% or m ore use in the dance scene.
The broad similarities between Tables I and 2  are striking. From Table l , depressant drugs (heroin, Buprenorphine. dihydrocodeine, Diazepam and solvents) are the drugs least often used in the dance drug scene. From Table 2 , depressants were more often used at a non-dance event setting. Conversely, of the ® ve illegal stimulant and hallucinogenic drugs (cocaine, Am phetamine, Psilocybin, LSD and Ecstasy), only cocaine and Psilocybin were m ost often last used in a non-dance setting. The three drugs with the m ost widespread use overall (alcohol, cannabis and tobacco) were also most often used in a non-dance setting.
To test the relationships between dance settings and drug use, Wilcoxon matched-pairs signed-ranks tests were conducted. This tested whether users of any two drugs were more likely to use one drug in a dance setting. These results are summarized in Table 3 . In this table, results from drugs that had fewer than 10 matchings with any other drug have been excluded. For each drug tested a dichotomous variable of last use at a dance event was created by comparing Can.
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Psi. *Cases where respondent co-used w ith Ecstasy but could not remember the order of use, did not state the order of use or used in m ore than one of the before, during and after categories are not shown. T he number of cases not shown for these reasons are for dihydrocodeine 1, Tem azepam 5, Diazepam 2, cocaine 6, Am phetam ine 2, Psilocybin 3, LSD 6, nitrites 4, Ketamine 2 and composite of all others 1. last use in the scene against use in all other settings (including house parties and work/other events). Table 3 lists the Z scores for each comparison between drugs by setting of use. From Table 3 , it is clear that the likelihood of having last used at a dance event differs greatly between drugs. The drug users in this sample were signi® cantly more likely to use Am phetamine, nitrites and Ecstasy at a dance event than any other substances. Next in order of likelihood of use as a dance drug were LSD and cocaine. Users were more likely to use these two drugs at a dance event than any (illicit) depressants (dihydrocodeine, Tem azepam, Diazepam), cannabis or tobacco, but not Psilocybin (in the case of cocaine) or alcohol (in both instances). Psilocybin was more likely to have last been used at dance event than Diazepam or cannabis. Alcohol was more likely to have been used at a dance event than either Diazepam, cannabis or tobacco. The rem aining substances have such low prevalence of use at dance events that they can scarcely be considered as dance drugs at all (though tobacco would appear more likely to have last been used at a dance event than canabis).
C ombining dance drugs and other substances
Although many drugs were seldom last used at a dance event, the possibility rem ains that these m ay have been used before or after attending a dance event. This presents the potential for dance drugs to be used in combination with other substances. The mixing of drugs in this way is referred to here as ª co-useº . As Ecstasy is the drug most often used in a dance setting, it is taken here as an example to illustrate this co-use phenomenon. Table 4 details patterns of co-use between Ecstasy and other drugs.
From Table 4 , a by now familiar grouping of drug categories is apparent. Depressant drugs, such as opiates and benzodiazepines, were never used at the same time as Ecstasy but were sometimes used afterw ards. Stimulants and hallucinogens were seldom used after Ecstasy, but were m ore likely to be used simultaneously. Hallucinogens (e.g. LSD) were rarely used before Ecstasy use, but some stimulants (e.g. Amphetamine) were. The frequency of alcohol, tobacco and cannabis use in this sample m akes it unlikely that these drugs would have last been used with Ecstasy by many respondents.
Discussion
Com paring data obtained from this study with those obtained in other drug use samples (for example, Hammersley et al., 1990, Lavelle et al., 1991) reveals differences in the types of drugs most commonly used. Respondents in the dance drug sample were more likely to be users of stimulants or hallucinogens (cocaine, Amphetamine, LSD, Psilocybin and Ecstasy) and less likely to be users of depressants (heroin, Buprenorphine, dihydrocodeine, Temazepam, Diazepam or solvents). None of the other Scottish drug research projects listed in the introduction speci® cally asked about nitrite or Ketamine use. The use of alcohol, tobacco and cannabis was as extensive in this sample as in any other. From Tables 1 to 3 a clear hierarchy of dance drug use in this Glasgow sample would seem to be emerging. There are three levels to this hierarchy. The ® rst level consists of tobacco, cannabis, opiates, benzodiazepines and solvents, which can be described as ª non-dance drugsº . Alcohol, cocaine, Ketamine and hallucinogens can be described as ª secondary dance drugsº and Amphetamine, nitrites and Ecstasy as ª primary dance drugsº . This three-level hierarchy is considered below.
Primary dance drugs
The prim ary dance drugs are Amphetamine, nitrites and Ecstasy. These three drugs were more often last used at a dance event than in all other settings combined.
Alhough nitrite action is that of a short-term stimulant, its high incidence of use on the dancē oor may be m ore related to availability. Nitrites are sometimes sold in clubs and bottles of ª poppersº are often passed around the crowd. As such, much nitrite use appears m ore incidental than intentional on the dance scene.
This leaves Ecstasy and Am phetamines as the preferred drugs of the dance scene. This is not surprising, as the stimulant effects of Ecstasy or Amphetamine would surely enhance or prolong the dancing experience. This con® rm s the ® nding of Henry (1992), who described Ecstasy as almost exclusively a dance drug. Amphetamine use is relatively common in other Scottish drug samples (e.g. Hammersley et al., 1990; M orrison & Plant, 1990; Lavelle et al., 1991) , but not Ecstasy. This seems to indicate that Ecstasy use is m ore closely associated with the dance scene than any other drug. However, this interpretation needs some caution. Data from the dance drug study were collected more recently and Ecstasy use may have increased in other drug-using subcultures. Also the dance drug data were collected as part of a study of Ecstasy users (plus controls).
From Table 4 , co-use of Ecstasy and the other prim ary dance drugs reveals an interesting contrast. Thirty-nine of the 46 co-users of Ecstasy and nitrites used nitrites at the same time as Ecstasy, usually at a dance event (four did not state when). This is similar to the pattern of co-use between Ecstasy and hallucinogens (e.g. LSD). Twenty-two of the 45 co-users of Amphetamine and Ecstasy used Am phetamine before Ecstasy, 14 at the same time and seven afterwards (two did not state when). This is similar to the pattern of co-use between Ecstasy and cocaine.
Secondar y da nce drugs
This is a varied group of substances with little in comm on except that in some cases their availability might deter their use as dance drugs.
Alcohol, like tobacco and cannabis, could be described as a ubiquitous drug. Unlike tobacco and cannabis, alcohol has some associations with the dance scene. Indeed, alcohol could be described as a traditional dance music drug (at discos, ceilidhs, barn or ballroom dances, etc). However, alcohol is also widely available and used in a variety of settings other than dance events.
Psilocybin is another drug that sometimes appears to be used on the dance scene. However, from Table 2 its main setting of use was outdoors. This re¯ects the natural hallucinogen' s growth in the countryside, parks and gardens around Glasgow, where respondents often both picked and used this drug. (This ® nding was con® rmed by mapping the data collected on where each drug was last used and last obtained.) The other hallucinogen (LSD) comm only used by this group has a more evenly spread setting of use. When either of these two hallucinogens were co-used with the primary dance drug Ecstasy, this tended to happen simultaneously (at the dance event itself). For example, Table 4 indicates that, of the 26 respondents who used LSD with Ecstasy, none stated that they used LSD after Ecstasy and only one before Ecstasy (six did not know or state when). The rem aining 19 used LSD and Ecstasy at the same time (usually at a dance event). There was a similar pattern of co-use between Ecstasy and the hallucinogenic anaesthetic, Ketamine. None of the seven co-users of these drugs used Ketamine after Ecstasy.
Ketamine is a drug that only recently has begun to be used illicitly (James, 1991; Lifeline, 1992) . This is perhaps why Ketamine has the oldest age of ® rst use in Table 1 . Of the 16 drug categories asked about here, Ketamine is the only drug that can be said to have arrived after the advent of the dance drug scene (assuming Ecstasy' s arrival as simultaneous). Previous articles have linked Ketamine use to the dance drug culture (James, 1991; Lifeline, 1992) . As such, it might have been expected that Ketamine use should be comm onplace in this sample. However, incidence of Ketamine use was relatively low. This appears to indicate that the drug has not become as prevalent on the Scottish dance scene as some press reports have indicated (ª Rave scene drug a killerº ; Glasgow Evening Tim es, 13/04/92). The muscle relaxant effects of this drug m ight also be seen as deterring its use as a dance drug.
Being a stimulant with a history of use in other dance drug scenes (Kohn, 1992; James 1994; Gilman, 1994) , cocaine m ay have been expected to have been last used m ore often at a dance event than was the case in this sample. From Table 2 , the most common place of cocaine use was in a house other than the user' s home. Heroin was the only other drug most often used in this setting. This m ight re¯ect cocaine and heroin often being considered together as ª hard drugsº . Indeed, previous research has found two types of cocaine users in Scotland: ª recreationalº drug users and heroin/opiate users (Hamm ersley & Ditton, 1994) . Interestingly co-use of cocaine with the primary dance drug, Ecstasy, often took place before Ecstasy use (before a dance event). From Table 4 , of the 29 co-users 10 took cocaine before Ecstasy, 10 at the same time and only three afterwards (six took continuously or did not state when). So, although few er than one-quarter of cocaine users last did so at a dance event, others may have used the drug before going there.
Non-dan ce drugs
From the data presented here, two types of substances cannot be described as dance drugs. The ® rst type of non-dance drugs may be described as ª ubiquitous drugsº , the second type as illegal drugs with depressant effects. ª U biquitous drugsº is a term used here to describe tobacco and cannabis. This term is used because of their widespread use in this sample and across other differen t drug samples (e.g. Hamm ersley et al., 1990; Lavelle et al., 1991) . In the dance drug group, both these substances had been used by almost the whole sample and for m ore than half the days in the past year (290 and 220 days, respectively, for those who had used in the last year). As such it is unlikely that these drugs would last have been used at a dance event. That is not to say that they are never used in a dance setting, merely that most users of these drugs would appear to do so on m ost days, no matter where they are. That said, there did appear to be a slight tendency for tobacco to be m ore likely to have last been used than cannabis at a dance event. Whether this is due to some individuals using tobacco specially for the enjoym ent of the rave or merely a re¯ection of the dif® culties involved in attempting to smoke cannabis in a nominally drug-free club is not known.
Illegal depressant drugs include opiates such as dihydrocodeine and benzodiazepines, such as Tem azepam or Diazepam. Although the number of users was few er, solvents also appear to ® t into this category. These are all drugs which have been viewed as problematic drugs, rather than dance drugs (Gilman, 1991 (Gilman, , 1993 . Also, it is perhaps unsurprising that the use of depressants should be low at dance events. The very nature of their effects would impair dancing ability. On the other hand, the legally condoned depressant drug, alcohol, is usually available at dance events and not just at dance drug scene events (raves).
This does not mean that these drugs are never associated with the dance drug scene, only that they are not used as an adjunct to dancing behaviour. Indeed, many users in the dance drug sample mentioned using depressants to help aid sleep after dancing while on primary dance drugs. For example, Table 4 shows that 44.8% of 68 Temazepam users said they last took this drug in conjunction with Ecstasy. Only one user of both these drugs took Temazepam before Ecstasy, the remainder afterwards (® ve did notspecify when). As Ecstasy was most often used in the dance scene and Temazepam rarely so, this suggests that Temazepam use in this group often took place after a night out dancing. From Table  2 , such use would appear m ost likely when the user returns home, goes to another house or at a post-dancing house party (such parties after dance drug events are known as chill-out parties).
From these data, Ecstasy appears to be the drug that is m ost often used at dance events. This often follows the use of stimulant drugs (Amphetamine and cocaine) and is often accompanied by hallucinogenic or anaesthetic-related drug use at the dance event. Later, depressant drugs (such as temazepam) may also be used as a ª come downº . This indicates that dance drug use is not only restricted to those drugs actually taken at the dance event, but includes others taken before or afterw ards. To this might also be added commonly used drugs such as alcohol, tobacco and cannabis, which from their high frequency of use (see Table 1 ) appears likely to be used by some people before, during or after a dance event.
C onc lusions
This sample of dance drug users was obtained in Glasgow by snowballing. This method has an obvious potential bias in that the patterns of drug use detailed above may be limited to the speci® c group contacted. However. the sampling of naturally occurring drug-using units may not always be a disadvantage when making population inferences (Kaplan, Korf & Sterk, 1987) . There may have been greater biases had this sample been obtained via drug agencies. Snowballing is a powerful research tool for contacting dif® cult to reach groups, such as dance drug users.
Another obvious limitation of this sample lies in patterns of drug use varying geographically and over time. This is especially the case when drug use is associated with the rapidly evolving world of youth fashion as in the rave scene. For example, James (1994) details a changing pattern of dance drug use in England, where cocaine rather than Tem azepam (as in Scotland) is identi® ed as a potential route into problem drug use. However, such changes over time and place are not only limited to dance drugs. Despite these obvious limitations several causes for concern arise from this study, which may have implications elsewhere.
These respondents were polydrug users and their use of differen t drugs often took place simultaneously. Such mixing of different drugs will of course increase the risk of drug-related harm . Health m essages aimed at safer dancing should therefore be aimed at the dangers of polydrug use and not simply targeted at a single substance such as Ecstasy (M DM A). The dance drugs equals M DM A equation as prom oted by the m edia is clearly inaccurate. Previously, the same sources in the Scottish m edia focused on a drug injection equals heroin use equation. At a time when there was a rapid increase in deaths among G lasgow drug injectors, the media and the police attributed this to high purity heroin (ª Death rate soars as heroin purity risesº , Scottish Daily Express, 02/11/95). This increase in drug deaths has since been demonstrated to have occurred because of poly-drug use (Hamm ersley et al., 1995) . Clearly there is a potential for future deaths in the dance scene to be misrepresented in the media as ª ecstasy overdosesº . Different drugs tended to be used in different settings. These settings might increase the potential for drug harm. For example, primary dance drugs tended to be stimulants. The use of stimulants is known to increase body temperature. At hot night clubs or raves, the use of such drugs has been linked to several deaths due to hypertherm ia-related causes (Henry, 1992) . The evidence found here suggests that Ecstasy and Am phetamine (temperature raising drugs) are those most often used in this dangerous environm ent. The use of depressant drugs, such as Tem azepam, after a dance event m ight also be described as taking place in a dangerous setting. Using such drugs at home m ay increase the risk of fatal overdose. This could happen because using late at night (perhaps alone and in colder temperatures than during the day) increases the chances of an overdose victim receiving m edical attention in adequate time. The setting of drug use is something that m ust also be important when considering the behaviour of other groups of drug users. For example, the secretive nature of drug injection may favour hazardous settings such as toilet cubicles or derelict buildings. Such settings m ay increase the risk of harm such as overdose, infection or hypotherm ia (Klee & M orris, 1995) .
The use of drugs such as Temazepam in the dance scene (even if at home afterwards) may encourage the dance drug users to take these drugs in other situations. In other Scottish drug-using samples, Temazepam use has been associated with problem drug users (Sakol, Stark & Sykes, 1989; Hammersley et al., 1990; Lavelle et al., 1991) . Thus, there is the potential for dance drug users to experience problems and appear at agencies through involvement with Temazepam. Despite these threats, the main risks related to dance drug use would appear to be those from acute intoxication rather than addiction.
